About Timothy Lu, M.D.
Form D filings for Candid Therapeutics in 2024 list Timothy Lu, M.D. as executive officer.
Timothy Lu, M.D. first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Timothy Lu, M.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Timothy Lu, M.D. works with at each company, as listed on that company's latest Form D.
Candid Therapeutics, Inc. · Form D, Sep 13, 2024
JD
Jeffrey Tong, Ph.D.
Director
AK
Arvind Kush
Executive officer
KD
Kenneth Song, M.D.
President and CEO, director
AD
Aaron Royston, M.D.
Director
BD
Bernie Huyghe, Ph.D.
Executive officer
MD
Michael Rome, M.D.
Director